Answers are grounded in this paper and cite their sources.
Currently, biomarkers research is focused on their use as tools to identify molecular endotypes and clinical phenotypes and to facilitate patient screening and monitoring in clinical trials. This approach should allow a more targeted management of patients suffering from osteoarthritis.
No takes yet. Share an insight, caveat, or question.
Yves Henrotin (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: